Formulations online webinar Conferences | Pharmaceutical Formulations Conferences | Drug Formulation Conferences | Drug Discovery Congress | Middle East | Europe | Asia | USA | 2019 | Conference Series LLC LTDFormulations Conferences | Pharmaceutical Formulations Conferences | Drug Formulation Conferences | Drug Discovery Congress | Middle East | Europe | Asia | USA | 2020

Theme: Visualizing the Future Effects of Chemistry and Novel Drug Delivery Systems for diseases like COVID-19

Formulations 2020

Scientific Program

Renowned Speakers

Volkmar Weissig
Midwestern University College of Pharmacy Glendale
USA

Steve Hood
GSK
UK

Arwyn T Jones
Cardiff University
UK

Osama Ibrahim
Bio Innovation
USA

Andreas Bernkop-SchnÃ¼rch
University of Innsbruck
Austria

Joel Richard
IPSEN
France

Felix Kratz
CytRx Corporation
Germany

Costas Kiparissides
Aristotle University of Thessaloniki
Greece

Amiram Goldblum
The Hebrew University of Jerusalem
Israel

Balint Sinko
Pion Inc
USA

Wafa T. Al-Jamal
University of East Anglia
UK

Paul Fisher
Inovio Pharmaceuticals Inc
USA

Serena Mazzucchelli
University of Milan
Italy

Khuloud Al Jamal
Kingâ€™s College London
UK

Gabriele Sadowski
TU Dortmund
Germany

Reno A L Leon
Structo Pte. Ltd.
Singapore

Dimitrios A. Lamprou,
University of Kent
UK

Raid Alany ,
Kingston University
UK

Sharareh Salar-Behzadi,
Research Center Pharmaceutical Engineering GmbH
Austria

Dagmar Fischer,
Friedrich-Schiller University
Germany

Bruno Sarmento,
University of Porto
Portugal

Imran Saleem,
Liverpool John Moores University
UK

Marta Truffi,
University of Milano
Italy

Satyanarayana Somavarapu,
UCL School of Pharmacy
UK

Sharif Abdelghany,
University of Jordan
Jordan

Marco Contardi,
Italian Institute of Technology
Italy

Fatma Demir Duman,
Koc University
Turkey

AntÃ³nio JosÃ© Ribeiro,
University of Coimbra
Portugal

Anselmo J. Otero-Gonzalez,
Havana University
Cuba

Pranav Shah,
Uka Tarsadia University
India

Muhammad Hanif,
Bahauddin Zakariya University
Pakistan

Fanzhu Li,
Zhejiang Chinese Medical University
China

Zaheer Ahmad,
Chinese Academy of Sciences
China

Peter Krajcsi,
Solvo Biotechnology
Hungary

Victoria Sherwood,
University of Dundee
UK

Flavia Laffleur,
University of Innsbruck
Austria

Maria Manuela Gasper,
University of Lisbon
Qatar

Maria Manuela Gasper,
University of Lisbon
Portugal

Fabienne Danhier,
Louvain Drug research Institute
Belgium

Gary Gellerman,
Ariel University
Israel

YÃ¼cel Baspinar,
Ege University
Turkey

Nashiru Billa,
University of Nottingham
Malaysia

Tatiana Hurtado de Mendoza,
Sanford Burnham Prebys Medical Discovery Institute
USA

B B Barik,
Jazan University
Saudi Arabia

Ehsan Shamaeli,
Tarbiat Modares University
Iran

Ruchi Bansal,
University of Twente
Netherlands

Nermin Salah Ahmed,
University in Cairo
Egypt

Kang Choon Lee,
SungKyunKwan University
South Korea

Shilpa Raut,
Amway
USA

Tina Kauss,
University of Bordeaux
France

Formulations 2020

ConferenceSeries Ltd is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. Currently we are bringing forth “23^rd International Conference and Exhibition on Pharmaceutical Formulations” (Formulation 2020) scheduled to be held during July 27-28, 2020 as an Online Webinar. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Formulations.

ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

2020 Highlights:

300+ Participation (70 Industry: 30 Academia)
5+ Keynote Speakers
50+ Plenary Speakers
14 Innovative Educational Sessions
5+ Workshops
B2B Meetings

Motives to attend:

Keynote presentation along with interactions to galvanize the scientific community.
Workshop and symposiums to reach the largest assemblage of participants from the Pharma/Biotech community.
A wide track of exhibitors to showcase the new and emerging technologies.
Platform to global investment community to connect with stakeholders in Pharma/Biotech sector.
Young Scientist/ Investigators Award geared towards best budding young research.
Links to the political marketing resources in order to expand your business and research network.
Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research.

Pharmaceutical Formulations 2020 has everything you need:

Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in Pharmaceutical sciences, where all attendees can interact with the panel followed by a Q&A session.

Speaker and Poster Presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.

Editorial Board Meeting: Discussing on growth and development of open access Pharmaceutical & Drug Development Journals and recruiting board members and reviewers who can support the journal.

Round Table Meetings: Providing a platform where industry professionals meet academic experts.

Over 50+ organizations and international pavilions will be exhibiting at Pharmaceutical Formulations 2020 conference. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.

The Pharmaceutical Formulations 2020 has everything you need, all under one roof, saving you both time and money. It is the event you cannot afford to miss!

Target Audience:

Directors, CEO’s of Organizations
Business Development Managers
Chief Scientific Officers
R&D Researchers from Pharmaceutical Industries
Professors, Associate Professors, Assistant Professors
PhD Scholars
Patent Attorneys
Intellectual Property Attorneys
Investment Analysts
Association, Association presidents and professionals
Noble laureates in Health Care and Medicine
Bio instruments Professionals
Bio-informatics Professionals
Software development companies
Research Institutes and members
Supply Chain companies
Manufacturing Companies
CRO and DATA management Companies
Training Institutes
Business Entrepreneurs

Young Scientist Benefits

Our conferences provide best Platform for your research through oral presentations.
Share the ideas with both eminent researchers and mentors.
Young Scientist Award reorganization certificate and memento to the winners
Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development
Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Track 1: Pharmaceutical Formulation

Pharmaceutical formulation is defined as the process in which different chemical substances are combined to produce a final medicinal product. Since 1991, we have been designing Liquid, Suspension, Powder, Solid solution, Semisolid formulations and even drug eluting devices.The formulation studies involve developing a preparation of drug acceptable for patient. Pharmaceutical Formulation is the word often used in a way that includes dosage form. Formulation studies consider factors such as solubility, particle size, polymorphism and pH as all of these can influence bioavailability and hence the activity of a drug.

Related Societies:

Societies in USA: Canadian Society for Pharmaceutical Sciences (CSPS), Pharmaceutical Manufacturers Association of Canada (PMAC), American Association of Pharmacy Technicians (AAPT), American Society of Health-System Pharmacists (ASHYP).

Societies in Europe: Belgian Society of Pharmaceutical Sciences (BGFW), European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Association of the British Pharmaceutical Industry (ABPI).

Societies in Asia and Pacific: The Pharmaceutical Society of Australia (PSA), Austrian Pharmaceutical Society (APS), Korean Research-based Pharmaceutical Industry Association (KRPIA), Kuwait Pharmaceutical Association (KPA).

Related Journals:

Journal of Pharmacology and Therapeutics; Journal of Therapeutic Advances in Drug Safety; Journal of Clinical Pharmacokinetics; Journal of Investigational New Drugs; Journal of Pharmaceutical Research, Journal of Drugs; Drug Metabolism Reviews, A Journal of Drug Formulation, Development and Production; Recent Patents on Drug Delivery & Formulation, Journal of Toxicology: Clinical Toxicology, Journal of Molecular Pharmaceutics & Organic Process Research, The pharmaceutical Journals

Track 2 : Solid Dosage Forms

Solid dosage formulations are important dosage forms in pharmaceuticals. e.g. tablets, capsules, granules, sachets, reconstitutable powders, powders, dry powder inhalers and chewables. Solid dosage form contains unit dose of one or more medicament. Easy to package and carry around, solid dosage forms are also difficult to tamper with, stable and easy to dose accurately – approximately 80% of errors in medication are associated with the use of liquid formulations. Excipients include Binders, Glidants, Sweeteners etc.,

Related Societies:

Related Journals:

The pharmaceutical Journals; Journal of Molecular Pharmaceutics & Organic Process Research; Journal of Pharmacology and Therapeutics; Journal of Therapeutic Advances in Drug Safety; Journal of Clinical Pharmacokinetics; Journal of Investigational New Drugs; Journal of Pharmaceutical Research, Journal of Drugs; Drug Metabolism Reviews, A Journal of Drug Formulation, Development and Production; Recent Patents on Drug Delivery & Formulation, Journal of Toxicology: Clinical Toxicology

Track 3: Semi-Solid Dosage Forms

Semi solid dosage forms are the products when applied to the skin treat a pathological condition and protects from other harmful environment. They are smooth,non-staining and get miscible with skin secretions. Creams, Gels, Pastes etc. are the examples. Semisolid dosage forms usually are intended for localized drug delivery. In the past few years, however, these forms also have been explored for the systemic delivery of various drugs. Semisolid dosage forms for dermatological drug therapy are intended to produce desired therapeutic action at specific sites in the epidermal tissue.

Related Societies:

Related Journals:

Journal of Drugs; A Journal of Drug Formulation; Journal of Pharmacology and Therapeutics; Journal of Therapeutic Advances in Drug Safety; Journal of Clinical Pharmacokinetics; Journal of Investigational New Drugs; Journal of Pharmaceutical Research; Drug Metabolism Reviews, ,Development and Production; Recent Patents on Drug Delivery & Formulation, Journal of Toxicology: Clinical Toxicology, Journal of Molecular Pharmaceutics & Organic Process Research, The pharmaceutical Journals

Track 4: Liquid Dosage Forms

Liquid dosage forms are essential Pharmaceutical products which involves a mixture of active drug components and nondrug components (excipients). Liquid dosage forms are prepared: a) by dissolving the active drug substance in an aqueous or non- aqueous (e.g. glycerin, ether, alcohol) solvent b) By suspending the drug in appropriate medium or c) By incorporating the drug substance into an oil or water phase. Ex: Suspension, Emulsion, Syrups, Elixers

Related Societies:

Related Journals:

Track 5: Gaseous Dosage Forms

Gaseous dosage forms are packed in a container which gets released upon applying pressure. The gas inside contains therapeutically active medicaments. The containers have valve systems with continuous or limited delivery. They are used for topical application on skin and as local application into nose and mouth.

Related Societies:

Related Journals:

Track 6: Types of Formulations

Formulations are classified into two types: based on Route of administration and Physical form. Based on route of administration they are classified as Oral, Topical, Rectal, Parenteral, Vaginal, Inhaled, Ophthalmic and octic. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect.

Related Societies:

Related Journals:

Track 7: Novel Drug Delivery Systems

“Novel Drug delivery System (NDDS) refers to the formulations, systems and technologies for transporting a pharmaceutical compound in the body as it is needed to safely achieve its desired therapeutic effects. Drug delivery systems (DDS), are based on approaches that are interdisciplinary and that combine pharmaceutics, bio conjugate chemistry, and molecular biology.

Related Societies:

Related Journals:

Track 8: General Considerations in Dosage Forms

Prior to formulation some physico chemical properties are characterized. Chemical properties include structure, form and reactivity. Physical properties include particle size, melting point and solubility. In case of some drugs biological properties are also characterized. Age and sex of the patient also play a major role in dosage design. The others factors are Solubility, Buffer capacity and partition coefficient.

Related Societies:

Related Journals:

Track 9: Drug Formulation Procedures

The drug subjected to drug development undergoes number of trials and are screened at different stages to produce a final potent drug for the treatment of various diseases. During this process different properties are checked to see whether the drug is non-toxic to living system and is therapeutic or not. Using suitable excipients and technological preparations the active substances are formulated into final dosage form. The final product is the Actual composition of preparation, manufacturing specification.

Related Societies:

Related Journals:

Track 10: Pharmaceutical Excipients

Pharmaceutical excipients are those substances other than the prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. There are many excipients. Few of them include Antiadherents, Binders, Coatings, Colors, Flavours, Lubricants, Preservatives, Sweeteners etc. Excipients are crucial to drug delivery within the body. Generally, an excipient has no medicinal properties. Its standard purpose is to streamline the manufacture of the drug product and ultimately facilitate physiological absorption of the drug.

Related Societies:

Related Journals:

Track 11: Drug Design and Development

Drug design, also known as rational drug design, is the inventive process of finding new medications based on the knowledge of a biological target. Drug design defines the design of molecules that are complementary in shape and charge to the bimolecular target with which they interact and therefore will bind to it. Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.

Related Societies:

Related Journals:

Track 12: Pharmaceutical Analysis

Pharmaceutical analysis is a branch of practical chemistry that involves a series of process for qualification, purification, identification and determination of a substance, separation of the components of a solution or mixture, or determination of structure of chemical compounds. The sample to be analysed is called as analyse. Pharmaceutical Analysis is an Analytical Method used to determination the quality and quantity of the pharmaceutical products. It also gives the information about the purity and safety of the products. Briefly it can be described as it identifies, determines, quantifies, purifies and separates the active compound from the mixture.

Related Societies:

Related Journals:

Track 13: Drug Product Manufacturing

The drug product manufacturing facility is designed to produce injectable in syringes or vials in Grade A environment. Industries strive to improve product quality in today’s competitive environment and as well reduce the production cost. Scaling up from our development services to full scale commercial drug product manufacture or transferring existing commercial products we can meet your commercial drug product manufacturing requirements.

Related Societies:

Related Journals:

Track 14: Smart Drug Delivery Systems

Targeted drug delivery sometimes called smart drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to other parts in the meantime reduce side effects/toxicity of payloads which are key factors for improving patient compliance.

Related Societies:

Related Journals:

Track 15: Pharmacists Role in Patient Safety

Pharmacists can play a role helping patients with chronic diseases have better medication at correct time and get good clinical outcomes. They play a key role in immunization services and identifying vaccine candidates. They Participate and maintain a significant role in multidisciplinary patient care rounds. Patients often make their own decisions about managing their medications. Pharmacists could usefully serve as patient advocates, providing information that permits patients to assess risk and enhance their autonomy.

Related Societies:

Related Journals:

Track 16: Regulatory Affairs

Regulatory affairs are a new profession which is developed by the governments to protect public health. The main aim is controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals and cosmetics. Regulatory affairs also have a very specific meaning within the healthcare industries.

Related Societies:

Related Journals:

Track 17: Pharmaceutical Formulations Market

Pharma industries are showing increased confidence in the growth of manufacturing in the market. This turn around in the market is due to the potential which is being driven by concerns of quality in some Asian markets and a marketed shift in the drug development. The primary reason behind this is an increased regulatory confidence in the standards of manufacturing.

Related Societies:

Related Journals:

Track 18: Entrepreneurs Investment Meet

Entrepreneurs who are ready to invest and get profit by working hard in the field of pharmaceutical formulations will be happy by attending this meeting and make their way a successful one by meeting intellectuals and experts who can make their investment worthwhile. This platform will be the best one to make a shape of your business.

Related Societies:

Related Journals:

Pharmaceutical Formulations Market Research:

Global Pharmaceutical Market 2019 Industry Research Report is a professional and in-depth study on the current state of the Global Pharmaceutical industry. This report studies Global Pharmaceutical in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India with production, revenue, consumption, import and export in these regions, from 2014 to 2019, and forecast to 2025.

The Global Pharmaceutical market 2019 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Pharmaceutical market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The global pharmaceuticals market was worth $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, according to a recent pharma market research report by The Business Research Company.

This is an accelerated pace compared to 5.2% for the years before 2017 but is slower than the other two large healthcare segments, medical equipment and healthcare services. Healthcare as a whole is growing at over 7% year on year.

The report also focuses on global major leading industry players of Global Pharmaceutical market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Global Pharmaceutical market development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions offered.

Formulations Market:

Pharmaceuticals represented a US$500 billion-a-year market globally as of 2019, the World Health Organization states. The global pharmaceutical market is expected to surpass US$800 billion by 2020, with the ten largest pharmaceutical companies collectively commanding about a third of the market. Companies in the pharmaceutical industry are characterized by their sizeable expenditure on R&D and marketing initiatives in a bid to rake in more revenue. The development of biopharmaceuticals represents a milestone for the industry and personalized therapies carry immense promise in the near future.

Although mature markets continue to account for over half of all global revenue of the pharmaceutical industry, both large and niche pharmaceutical companies are now waking up to the lucrative potential that lies in growth markets. Costs associated with bringing new molecules to the commercial space are progressively rising. To add to this, new medicines launches have continued to chart a flat graph. This could, however, also be an enormous opportunity for pharmaceutical companies in both mature and growth markets.

Scope & Importance:

Pharmaceutical marketing is the last element of an information continuum, where research concepts are transformed into practical therapeutic tools and where information is progressively layered and made more useful to the health care system. Thus, transfer of information to physicians through marketing is a crucial element of pharmaceutical innovation. By providing an informed choice of carefully characterized agents, marketing assists physicians in matching drug therapy to individual patient needs. Pharmaceutical marketing is presently the most organized and comprehensive information system for updating physicians about the availability, safety, efficacy, hazards, and techniques of using medicines. The costs of pharmaceutical marketing are substantial, but they are typical of high-technology industries that must communicate important and complex information to sophisticated users. These costs are offset by savings resulting from proper use of medicines and from lower drug costs owing to price competition.

Advanced Drug Delivery Systems

• The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%. • The North American market should grow from nearly $75.7 billion in 2015 to $93.4 billion by 2020, a CAGR of 4.3%. • The European market should grow from roughly $57.3 billion in 2015 to nearly $72.1 billion by 2020, a CAGR of 4.7%.

Antibiotics

• The global systemic antibiotics market should reach nearly $44.7 billion in 2020 from nearly $40.6 billion in 2015 at a compound annual growth rate (CAGR) of 2.0% from 2015 to 2020.

• The beta-lactams market should reach over $22.0 billion by 2020 from over $20.6 billion in 2015, a CAGR of 1.3% from 2015 to 2020.

• The other antibiotic classes market should reach over $10.6 billion in 2020 from nearly $8.3 billion in 2015, a CAGR of 5.0% from 2015 to 2020.

Excipients in Pharmaceuticals

• The global excipients market should reach nearly $6.9 billion by 2020 from over $6.2 billion in 2015, a compound annual growth rate (CAGR) of 1.9% from 2015 to 2020.

• The organic excipients market should reach $6.3 billion by 2020 from nearly $5.8 billion in 2015, a CAGR of 1.7% from 2015 to 2020.

• The inorganic excipients market should reach $433.7 million by 2020 from $351.9 million in 2015, a CAGR of 4.3% from 2015 to 2020.

Ophthalmic Therapeutic Drugs

• The global ophthalmic therapeutic drug market was valued at $12.3 billion in 2014. This market is expected to reach $19 billion by 2020, with a compound annual growth rate (CAGR) of 9.1% from 2014 to 2020. • The global age-related macular degeneration (AMD) market is expected to grow to nearly $7.9 billion by 2019 from nearly $5.4 billion in 2014, a CAGR of 7.8% from 2014 to 2020. • The global glaucoma therapeutic market generated revenue of $3.8 billion in 2014, and by 2020 this segment is expected to generate $6.4 billion, with a CAGR of 11.1% from 2014 to 2020.

Target Audience:

• Drug Delivery Technology Manufacturers

• Public and Private Physicians

• Healthcare Institutions (Medical Data Centers)

• Research & Clinical Laboratories

• Distributors and Suppliers of Drug Delivery Technologies

• Health Insurance Payers

• Market Research and Consulting Firms

Related Companies/Industries:

Novartis	Roche	Johnson & Johnson	Merck
Sanofi	Pfizer	Bayer	Eli lily
Amgen	AstraZeneca	AbbVie	Celgene
GlaxoSmithKline	Boehringer Ingelheim	Bristol-Myers Squibb	Takeda Pharmaceutical
Otsuka	Novo Nordisk	Gilead Sciences	Biogen Idec
Allergen	Actavis	Shire	Mylan
Actelion	Ipsen	Novozymes	Zoetis

Association & Societies:

Academy of Managed Care Pharmacy (AMCP)
Accreditation Council for Pharmacy Education
Alabama Board of Pharmacy
American Association of Colleges of Pharmacy (AACP)
American Association of Pakistani Pharmaceutical Scientists
American Association of Pharmaceutical Scientists (AAPS)
American Association of Pharmacy Technicians (AAPT)
American College of Clinical Pharmacology
American College of Clinical Pharmacy (ACCP)
American Institute of the History of Pharmacy
American Pharmacists Association (APhA)
American Society for Clinical Pharmacology and Therapeutics
American Society of Consultant Pharmacists (ASCP)
American Society of Health-System Pharmacists
American Society of Pharmacognosy
Arkansas State Board of Pharmacy
Association of Pharmacy Technicians UK
Board of Pharmaceutical Specialties
World Health Organization (WHO)
International Pharmaceutical Federation (FIP)

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	July 27-28, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View